Study guide
15.1 Enteral Nutrition: Indications & Access
Board Certified Specialist in Pediatric Nutrition CSP
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 CSP Exam Facts, Format & Fees 1.2 Eligibility & Application Process 1.3 Scoring, Test Day Logistics & Study Strategy
2 Pediatric Growth & Development
2.1 Growth Patterns Across Pediatric Age Bands 2.2 Developmental Milestones & Feeding Skill Acquisition
3 Human Milk & Infant Formulas
3.1 Human Milk & Lactation Management 3.2 Milk Handling, Storage, Donor Milk & Fortification 3.3 Infant & Specialized Formulas
4 Age-Appropriate Nutrition & Foods
4.1 Complementary Feeding & Toddler Nutrition 4.2 School-Age & Adolescent Nutrition
5 Prematurity & the NICU Graduate
5.1 Preterm Nutrition in the NICU 5.2 Post-Discharge Nutrition for Preterm Infants
6 Congenital, Developmental & Metabolic Conditions
6.1 Congenital & Neurodevelopmental Conditions 6.2 Inborn Errors of Metabolism
7 GI Disorders & Food Allergy
7.1 Gastrointestinal Disorders: IBD, Celiac, Short Bowel & GERD 7.2 Food Allergy, FPIES & Eosinophilic Esophagitis
8 Body System & Organ Dysfunction
8.1 Cystic Fibrosis & Respiratory Support 8.2 Congenital Heart Disease & Cardiac Conditions 8.3 Chronic Kidney Disease, Dialysis & Transplant
9 Oncology, Endocrine & Weight-Related Care
9.1 Pediatric Oncology & HSCT Nutrition 9.2 Diabetes Management & Ketogenic Diet Therapy 9.3 Pediatric Overweight & Obesity (AAP 2023 Guideline) 9.4 Eating Disorders, ARFID & Pediatric Feeding Disorder
10 Clinical Status & Health History
10.1 Medical Treatment & Medication History 10.2 Nutrition & Supplementation History 10.3 Cultural & Psychosocial Factors 10.4 Activity & Lifestyle History 10.5 Birth, Perinatal & Surgical History
11 Anthropometrics & Growth Assessment
11.1 Anthropometric Measurement Techniques 11.2 Growth Charts & Z-Score Interpretation 11.3 Growth Assessment in Preterm & Special Populations 11.4 Pediatric Malnutrition: AND/ASPEN Consensus Criteria 11.5 Body Composition Assessment in Children
12 Physical Exam, Laboratory Data & Nutrition Diagnosis
12.1 Nutrition-Focused Physical Exam 12.2 Diagnostic & Laboratory Testing 12.3 Micronutrient Status Assessment & Deficiency Workup 12.4 Gastrointestinal Function & Diagnostic Testing 12.5 Nutrition Diagnosis, PES Statements & the NCP
13 Estimation of Nutritional Needs
13.1 Energy Needs Across Age & Clinical State 13.2 Protein & Fluid Requirements 13.3 Micronutrient Needs & Catch-Up Growth 13.4 Estimating Needs in Critical Illness & Special Clinical States
14 Oral Nutrition & Supplementation
14.1 Oral Nutrition & Therapeutic Diet Modification 14.2 Texture Modification & Dysphagia Management 14.3 Vitamin & Mineral Supplementation
15 Enteral Nutrition Support
15.1 Enteral Nutrition: Indications & Access 15.2 Enteral Formula Selection 15.3 Feeding Regimens, Advancement & Complications
16 Parenteral Nutrition Support
16.1 PN Indications & Composition 16.2 PN Initiation, Advancement & Monitoring 16.3 PN Complications & IFALD
17 Care Planning, Coordination & Education
17.1 Monitoring & Evaluation of Nutrition Care 17.2 Interdisciplinary Coordination & Transitions of Care 17.3 Access to Food & Healthcare: Federal Programs 17.4 Education & Counseling for Children & Families 17.5 Documentation, Quality & Outcomes in Pediatric Nutrition Care 17.6 Ethics, Palliative Care & Nutrition Decision-Making
15.1 Enteral Nutrition: Indications & Access
Key Takeaways Explain This Topic AI
Enteral nutrition is indicated whenever the gastrointestinal tract is functional and the child cannot meet nutrient needs orally; the guiding principle is "if the gut works, use it."
The duration decision rule: anticipated therapy of 4–6 weeks or less favors a nasogastric or nasojejunal tube; therapy expected to last longer than 4–6 weeks (often cited as >8–12 weeks in ESPGHAN guidance) favors gastrostomy or jejunostomy placement.
Gastric feeding is physiologically preferred; post-pyloric (jejunal) feeding is reserved for gastroparesis, persistent vomiting, or documented aspiration of gastric contents, and jejunal feeds must run continuously.
Absolute contraindications to enteral feeding include bowel obstruction, ileus, and hemodynamic instability with gut ischemia; severe refractory malabsorption is a relative contraindication.
Radiographic confirmation remains the gold standard for verifying initial placement of a blindly inserted feeding tube; feeding should never begin on an unverified tube.
Last updated: August 2026
Indications for Enteral Nutrition
Enteral nutrition (EN) is the delivery of nutrients into the gastrointestinal (GI) tract via a tube, stoma, or the mouth when oral intake alone cannot sustain growth and health. The overriding principle, cited across ASPEN, ESPGHAN, and AND guidance, is "if the gut works, use it" : any child with a functional GI tract who cannot meet nutrient needs by mouth is a candidate for EN rather than parenteral nutrition.
Common pediatric indications include:
Inability to meet needs orally — generally operationalized as persistent intake below roughly 50–60% of estimated requirements, or dependence on excessive feeding time that impairs quality of life (common in neurologic impairment, cerebral palsy, and complex congenital heart disease).
Dysphagia with aspiration risk — oropharyngeal incoordination in prematurity, craniofacial anomalies, or neurodegenerative disease; videofluoroscopic swallow study (VFSS) demonstrating aspiration is the usual trigger.
Failure to thrive (FTT) — chronic malnutrition unresponsive to oral nutrition intervention, including cystic fibrosis with weight loss, chronic kidney disease, cholestatic liver disease, and cancer cachexia.
Chronic disease with increased requirements — congenital heart disease awaiting surgery, bronchopulmonary dysplasia, and inflammatory bowel disease (note: exclusive enteral nutrition is first-line induction therapy for pediatric Crohn's disease in ESPGHAN/ESPGHAN-endorsed guidance).
Critical illness — early EN (within 24–48 hours) is associated with improved outcomes in pediatric intensive care when the child is hemodynamically stable.
Contraindications
Absolute contraindications are few: mechanical bowel obstruction, ileus, hemodynamic instability requiring escalating vasopressor support with concern for gut ischemia, and active necrotizing enterocolitis. Relative contraindications include severe refractory malabsorption (e.g., ultra-short bowel early in adaptation), intractable vomiting or diarrhea despite management, and high-output enterocutaneous fistula. When the gut is unusable, the alternative is parenteral nutrition — an exam-favorite comparison point.
Access Device Selection
Device choice is driven by two questions: How long is therapy expected to last? and Does the child need gastric or post-pyloric feeding?
The Duration-of-Therapy Decision Rule
- Expected duration Preferred access
- < 4–6 weeks Nasogastric (NG) or nasojejunal (NJ) tube
- > 4–6 weeks (ESPGHAN often states > 8–12 weeks) Gastrostomy, gastrojejunostomy (GJ), or jejunostomy
Nasal tubes are quick and avoid anesthesia, but carry cumulative risks with long-term use: sinusitis, nasal septum pressure injury, esophageal erosion, frequent dislodgement, and social stigma in school-age children. A classic exam trap is the vignette in which a child has been cycling through NG tubes for months — the correct answer is to discuss gastrostomy, not to replace the NG tube again.
Gastric Access Options
NG tube — placed at the bedside; ideal for short-term feeding, trial feeding, or pre-operative nutrition support. Placement verification is a safety-critical exam topic: radiography is the gold standard for confirming initial placement of a blindly inserted tube. Aspirate pH ≤ 5.5 supports gastric position but is unreliable in children on acid suppression; auscultation alone is never acceptable.
Gastrostomy (G-tube) — for long-term therapy. Three placement routes:
PEG (percutaneous endoscopic gastrostomy) — most common; performed under endoscopic guidance with sedation, less invasive than surgery, shorter procedure time, and generally lower cost.
Surgical gastrostomy (open or laparoscopic) — preferred when a concurrent Nissen fundoplication is planned for severe gastroesophageal reflux disease (GERD), or when anatomy precludes endoscopy (e.g., prior gastric surgery).
Radiologically inserted gastrostomy (RIG) — performed by interventional radiology under fluoroscopy; an option when endoscopy is contraindicated or unavailable, though push-type PEG and RIG differ in tube caliber and peritonitis risk profile.
Low-profile ("button") devices are typically placed once the tract matures (about 6–8 weeks for a PEG tract, longer — around 3 months — after surgical or radiologic placement) and are favored for active or school-age children.
Gastric vs Post-Pyloric Feeding
Gastric feeding is physiologically preferred: it preserves the antimicrobial barrier of gastric acid, permits bolus feeding that mimics meals, allows osmotic mixing in the stomach, and supports normal hormonal responses. Post-pyloric (transpyloric) feeding is reserved for specific problems:
- Gastroparesis or severely delayed gastric emptying
- Recurrent vomiting or aspiration of gastric contents despite medical management
- Severe GERD with aspiration where fundoplication is deferred
- Anatomic issues (e.g., gastric compression, tracheoesophageal concerns)
For short-term post-pyloric access, an NJ tube is used. For long-term needs, options are a gastrojejunostomy (GJ) tube through an existing gastrostomy tract — practical because the gastric port allows venting and medication delivery — or a surgical jejunostomy (J-tube) when gastric access is impossible or unsafe. A key exam point: the jejunum has no reservoir capacity, so jejunal feeds must be delivered continuously , never by bolus, or dumping and cramping result. A second trap: GJ jejunal ports are small-bore and clog easily with medications; crushing extended-release tablets into a jejunal tube is both an occlusion risk and a pharmacologic error.
Putting It Together: A Worked Scenario
A 3-year-old with cerebral palsy, weight-for-length below the 1st percentile, safe swallow on VFSS but taking 90 minutes per meal, has been on NG feeds for 3 months with two unplanned ED visits for dislodged tubes. Expected need is years. Correct selection: gastrostomy with gastric bolus feeding — duration clearly exceeds 4–6 weeks, swallow is safe, gastric feeding is physiologic, and a low-profile button will improve quality of life. If the same child had documented aspiration of gastric contents and vomiting despite a proton pump inhibitor, the answer shifts to post-pyloric access (GJ or jejunostomy with continuous feeds, or gastrostomy with fundoplication depending on the GERD severity).